发明名称 New tetrahydro-pyrido-[4,3-d]-pyrimidines and processes for their preparation
摘要 <FORM:1028405/C2/1> The invention comprises 5,6,7,8-tetrahydropyrido-[4,3-d]-pyrimidines of the formula in which R represents a hydrogen atom, or an alkyl group in the 7- or 8-position, R1 represents an aminoalkyl (including a mono- or di-substituted aminoalkyl), alkoxyalkyl, cycloalkyl, aryl or aralkyl group, and R2 represents a hydrogen atom, a hydroxy, alkyl, aryl or aralkyl group, a free or mono- or di-substituted amino group, a nitrogen-containing saturated heterocyclic ring (which may contain a further hetero atom and/or be alkyl- or hydroxyalkyl-substituted) linked to the 2-position of the pyrimidine ring via the nitrogen atom, or an alkylthio or aralkylthio group; non-toxic acid addition salts thereof; and a process for their preparation comprising reacting a piperidone carboxylic acid ester of the formula <FORM:1028405/C2/2> in which Alk is an alkyl group, or an acid addition salt thereof, with a compound of the formula <FORM:1028405/C2/3> or an acid addition salt thereof, and, if desired' converting the compound thus formed to non-toxic acid addition salt of a compound of Formula I. The compounds in which R2 represents a free or mono- or di-substituted amino group, or a saturated heterocyclic ring as defined above, may also be prepared by reacting a compound of Formula I in which R2 represents a mercapto, alkylthio, aralkylthio or halo-aralkylthio group with ammonia or an appropriate primary or secondary amine, and, if desired, the compound of Formula I thus formed may be converted to a non-toxic acid addition salt thereof. Piperidone carboxylic acid esters of Formula II are prepared by the Dieckmann condensation of an ester of the formula <FORM:1028405/C2/4> Pharmaceutical compositions having anti-pyretic, antiphlogistic, diuretic, bacteriostatic, sedative or coronary-dilatory activity for oral, rectal or parenteral administration comprise a compound of the invention together with a pharmaceutical carrier or excipient. The compositions may be formulated as tablets, coated tablets, capsules, suspensions, ampoules or suppositories.
申请公布号 GB1028405(A) 申请公布日期 1966.05.04
申请号 GB19630010639 申请日期 1963.03.18
申请人 KARL THOMAE G.M.B.H. 发明人
分类号 C07D471/04 主分类号 C07D471/04
代理机构 代理人
主权项
地址